EBMT Harmonizes Viral CNS Infection Care After HSCT and CAR T-Cell Therapy
This EBMT Practice Harmonization and Guidelines Committee consensus provides the first standardized definitions, CSF PCR panel, empiric antiviral algorithm (foscarnet versus acyclovir), and response criteria for viral encephalitis, meningitis, and myelitis in transplant and cellular therapy recipients.
📅 Journal publication: Nov 2026(online Nov 5, 2026)·Last updated: Nov 16, 2026
★ Editor's PickEBMT Practice Harmonization and Guidelines Committeeviral encephalitismeningitismyelitisHSCTCAR T-cell therapyfoscarnetacyclovirganciclovirletermovirHHV-6Infectious Disease / Antimicrobials
Background Information
New guidelines tackle deadly CNS infections after cancer therapies.
Infectious complications like viral encephalitis, meningitis, and myelitis post-transplant and CAR T-cell therapy have high mortality rates and are often underdiagnosed. The guideline standardizes diagnostic categories, introduces a diagnostic algorithm, and recommends immediate empirical antiviral treatment. While providing useful guidelines, these rely largely on expert opinion and observational data, highlighting the need for further research. Standardized guidelines aim to improve diagnosis and treatment of viral CNS complications post-HSCT and CAR T-cell therapy.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Piñana JL, Cesaro S, Styczynski J, Schmidt-Hieber M, Mikulska M, Neofytos D, Baccelli F, Navarro D, Onida F, Ruggeri A, Sanchez-Ortega I, Camara R, Averbuch D, Yakoub-Agha I, Ljungman P
Citation:Piñana JL, Cesaro S, Styczynski J, et al. Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1-viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT. EClinicalMedicine. 2026;101:104312. doi:10.1016/j.eclinm.2026.104312